Please use this identifier to cite or link to this item:
https://doi.org/10.1039/c1ob05733b
DC Field | Value | |
---|---|---|
dc.title | Combinatorial synthesis of galactosyl-1,3,5-triazines as novel nucleoside analogues | |
dc.contributor.author | Wang, S. | |
dc.contributor.author | Lee, W.S. | |
dc.contributor.author | Ha, H.-H. | |
dc.contributor.author | Chang, Y.-T. | |
dc.date.accessioned | 2014-06-23T05:34:31Z | |
dc.date.available | 2014-06-23T05:34:31Z | |
dc.date.issued | 2011-10-21 | |
dc.identifier.citation | Wang, S., Lee, W.S., Ha, H.-H., Chang, Y.-T. (2011-10-21). Combinatorial synthesis of galactosyl-1,3,5-triazines as novel nucleoside analogues. Organic and Biomolecular Chemistry 9 (20) : 6924-6926. ScholarBank@NUS Repository. https://doi.org/10.1039/c1ob05733b | |
dc.identifier.issn | 14770520 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/75777 | |
dc.description.abstract | Herein we report a parallel solid-phase synthesis of 1,3,5-triazine based nucleoside analogues by a three-step substitution, starting from 2,4,6-trichloro-1,3,5-triazine. A library of 80 galactosyl-1,3,5-triazine compounds was prepared in high purity without extensive reaction conditions or tedious purification, suggesting the generality of this method. © 2011 The Royal Society of Chemistry. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1039/c1ob05733b | |
dc.source | Scopus | |
dc.type | Article | |
dc.contributor.department | LIFE SCIENCES INSTITUTE | |
dc.contributor.department | CHEMISTRY | |
dc.description.doi | 10.1039/c1ob05733b | |
dc.description.sourcetitle | Organic and Biomolecular Chemistry | |
dc.description.volume | 9 | |
dc.description.issue | 20 | |
dc.description.page | 6924-6926 | |
dc.identifier.isiut | 000295889900009 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.